Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK. Electronic address: d.arachchillage@imperial.ac.uk.
Drj
D
Arachchillage
Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
R
R
Reynolds
Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
T
T
Devey
Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
R
R
Maclean
Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
S
S
Kitchen
Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
J J
JJ
van Veen
D000328:Adult; D000368:Aged; D001835:Body Weight; D065427:Factor Xa Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008016:Life Change Events; D008297:Male; D008875:Middle Aged; D050177:Overweight / Q000150:complications*; D012008:Recurrence; D000069552:Rivaroxaban / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000150:complications* / Q000188:drug therapy*
D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban
Extremes of body weight; Rivaroxaban; Safety; Treatment outcome; Venous thromboembolism